Literature DB >> 22009328

Rheumatoid arthritis: HDAC and HDACi: pathogenetic and mechanistic insights.

Jenny Buckland.   

Abstract

Entities:  

Year:  2011        PMID： 22009328     DOI： 10.1038/nrrheum.2011.162

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  2 in total

1.  Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients.

Authors:  Justin Gillespie; Sinisa Savic; Chi Wong; Aiden Hempshall; Martyn Inman; Paul Emery; Ronald Grigg; Michael F McDermott
Journal:  Arthritis Rheum       Date:  2012-02

2.  Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay.

Authors:  Aleksander M Grabiec; Olexandr Korchynskyi; Paul P Tak; Kris A Reedquist
Journal:  Ann Rheum Dis       Date:  2011-09-27       Impact factor: 19.103
  2 in total
  6 in total

1.  Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid.

Authors:  Kanagaraj Subramanian; Darren M Hutt; Samantha M Scott; Vijay Gupta; Shu Mao; William E Balch
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

Review 2.  Targeting Histone Deacetylases in Diseases: Where Are We?

Authors:  Rosaria Benedetti; Mariarosaria Conte; Lucia Altucci
Journal:  Antioxid Redox Signal       Date:  2014-03-06       Impact factor: 8.401

3.  Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiency.

Authors:  Marion Bouchecareilh; Darren M Hutt; Patricia Szajner; Terence R Flotte; William E Balch
Journal:  J Biol Chem       Date:  2012-09-20       Impact factor: 5.157

4.  Connecting the dots from fatty acids to nonalcoholic steatohepatitis: epigenetics in the spotlight.

Authors:  Florin M Selaru; Frank A Anania
Journal:  Hepatology       Date:  2013-07-01       Impact factor: 17.425

5.  Largazole, a class I histone deacetylase inhibitor, enhances TNF-α-induced ICAM-1 and VCAM-1 expression in rheumatoid arthritis synovial fibroblasts.

Authors:  Salahuddin Ahmed; Sharayah Riegsecker; Maria Beamer; Ayesha Rahman; Joseph V Bellini; Pravin Bhansali; L M Viranga Tillekeratne
Journal:  Toxicol Appl Pharmacol       Date:  2013-04-28       Impact factor: 4.219

6.  Epigenetics and autoimmune diseases.

Authors:  Paula Quintero-Ronderos; Gladis Montoya-Ortiz
Journal:  Autoimmune Dis       Date:  2012-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.